Skip to main content
. Author manuscript; available in PMC: 2013 Mar 19.
Published in final edited form as: Biomaterials. 2011 Jul 23;32(30):7432–7443. doi: 10.1016/j.biomaterials.2011.06.027

Figure 6.

Figure 6

cdc42 activation assay. Heparin nanoparticles with high density loading have a statistically significant increase in cdc42 activation over soluble VEGF. The polystyrene particles do no have a significant enhancement over the soluble condition (n = 5, *p < 0.05).